Dr. Robert James Larke , MD
Urology • Crestview Hills, KY
350 Thomas More Pkwy, Suite 200
Crestview Hills, KY 410175465
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 5, 2010; this date does not establish years in practice.
-
Published CMS data list 17,484 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0897 — Injection, denosumab, 1 mg: 5,040 service units.
- J1952 — Leuprolide injectable, camcevi, 1 mg: 2,730 service units.
- J9155 — Injection, degarelix, 1 mg: 2,640 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 44 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,363 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 559 prescription fills, including refills.
- Abiraterone Acetate — 346 prescription fills, including refills.
- Finasteride — 344 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 23 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Kentucky (2024, 100 clinicians with data). Median for this group: 1,090. Middle half: 540 to 2,252.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 11,209 in 2020 to 17,484 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
350 Thomas More Pkwy
Suite 200
Crestview Hills, KY 410175465
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Kentucky Rehabilitation Services, Inc.; Tri State Urologic Services Psc Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Cincinnati College Of Medicine
2010
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
563 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $491,885 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $386,474 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
4,474 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$5,711,912 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,538.74 across 79 records.
By nature of payment
- Food and Beverage: $2,470.74 across 78 records.
- Education: $68.00 across 1 record.
Reporting-company totals (3 largest of 28)
- Calyxo, Inc.: $461.30 across 4 records.
- Boston Scientific Corporation: $167.69 across 4 records.
- Sumitomo Pharma America, Inc.: $167.08 across 8 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
16 years (graduated 2010)
CMS Doctors and Clinicians data list 2010 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2010
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Larke has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Larke as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Crestview Hills and Kentucky
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Kentucky (2024, 100 clinicians with data). Median for this group: 1,090. Middle half: 540 to 2,252.
Too few clinicians listed under Urology in Crestview Hills have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Kentucky (2024, 100 clinicians with data). Median for this group: $83,919. Middle half: $49,700 to $151,170.
Too few clinicians listed under Urology in Crestview Hills have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Kentucky (2024, 100 clinicians with data). Median for this group: $61,913. Middle half: $34,934 to $111,453.
Too few clinicians listed under Urology in Crestview Hills have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Urology in Kentucky (2024, 104 clinicians with data). Median for this group: 1,335. Middle half: 399 to 2,259.
Too few clinicians listed under Urology in Crestview Hills have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Kentucky (2024, 104 clinicians with data). Median for this group: $115,194. Middle half: $17,745 to $283,069.
Too few clinicians listed under Urology in Crestview Hills have Medicare Part D data for 2024 to compare.
9 active clinicians are listed under Urology with a practice address in Crestview Hills, KY (168 in Kentucky).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 56% from 11,209 in 2020 to 17,484 in 2024.
- 2020: 11,209
- 2021: 9,972
- 2022: 9,012
- 2023: 9,995
- 2024: 17,484
-
Medicare-allowed amount
Medicare-allowed amount increased 52% from $322,906 in 2020 to $491,885 in 2024.
- 2020: $322,906
- 2021: $295,214
- 2022: $328,195
- 2023: $412,224
- 2024: $491,885
-
Paid by Medicare
Paid by Medicare increased 53% from $252,403 in 2020 to $386,474 in 2024.
- 2020: $252,403
- 2021: $229,983
- 2022: $253,706
- 2023: $322,000
- 2024: $386,474
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 71% from 1,383 in 2020 to 2,363 in 2024.
- 2020: 1,383
- 2021: 1,570
- 2022: 1,577
- 2023: 1,962
- 2024: 2,363
-
30-day fills
30-day fills increased 73% from 2,586 in 2020 to 4,474 in 2024.
- 2020: 2,586
- 2021: 2,771
- 2022: 2,924
- 2023: 3,698
- 2024: 4,474
-
Part D drug cost
Part D drug cost increased 404% from $1,134,247 in 2020 to $5,711,912 in 2024.
- 2020: $1,134,247
- 2021: $2,027,518
- 2022: $2,428,468
- 2023: $4,568,315
- 2024: $5,711,912
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 67% from $1,516.23 in 2021 to $2,538.74 in 2025.
- 2021: $1,516.23
- 2022: $8,779.17
- 2023: $2,634.33
- 2024: $3,184.83
- 2025: $2,538.74
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 79 records totaling $2,538.74.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Calyxo, Inc. |
Food and Beverage
In-kind items and services
|
CVAC ASPIRATION SYSTEM | General | $264.00 |
| Calyxo, Inc. |
Food and Beverage
In-kind items and services
|
CVAC ASPIRATION SYSTEM | General | $158.50 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $138.54 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $124.22 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $115.02 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $68.00 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $67.28 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $56.94 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $41.20 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $37.85 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $34.96 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Tlando | General | $34.43 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $33.85 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ULTOMIRIS | General | $29.39 |
| ConvaTec Inc. |
Food and Beverage
In-kind items and services
|
— | General | $29.33 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $29.20 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $28.93 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $28.60 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $28.53 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $27.99 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
UROLIFT | General | $27.91 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $27.37 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $27.34 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $27.18 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $26.98 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
5,040 | 39 | $26.71 | $24.43 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
2,730 | 39 | $177.50 | $55.96 |
|
J9155
Injection, degarelix, 1 mg
|
2,640 | 11 | $5.00 | $4.15 |
|
J9030
Bcg live intravesical instillation, 1 mg
|
2,500 | 21 | $9.00 | $2.87 |
|
81002
Urinalysis, manual test
|
720 | 397 | $26.00 | $3.38 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
693 | 372 | $278.00 | $124.03 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
589 | 380 | $35.00 | $16.29 |
|
84153
Psa (prostate specific antigen) measurement, total
|
393 | 221 | $71.00 | $17.76 |
|
36415
Insertion of needle into vein for collection of blood sample
|
339 | 177 | $32.00 | $8.58 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
261 | 56 | $212.00 | $63.03 |
|
84403
Testosterone (hormone) level, total
|
162 | 58 | $101.00 | $24.40 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
118 | 90 | $97.00 | $10.32 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
105 | 40 | $159.00 | $48.15 |
|
80053
Blood test, comprehensive group of blood chemicals
|
101 | 32 | $39.00 | $10.35 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
92 | 50 | $151.00 | $32.50 |
|
84154
Psa (prostate specific antigen) measurement, free
|
72 | 59 | $85.00 | $18.02 |
|
86316
Analysis for detection of tumor marker
|
70 | 57 | $51.00 | $20.39 |
|
96372
Injection of drug or substance under skin or into muscle
|
68 | 39 | $124.50 | $13.90 |
|
82310
Calcium level, total
|
60 | 29 | $15.00 | $4.66 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
55 | 40 | $98.00 | $22.01 |
|
51720
Instillation of anti-cancer drug into bladder
|
53 | 22 | $482.00 | $85.25 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
50 | 50 | $438.00 | $160.80 |
|
G0023
Principal illness navigation services by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a patient navigator; 60 minutes per calendar month, in the following activities: person-centered assessmen
|
43 | 28 | $150.00 | $78.65 |
|
51702
Simple insertion of temporary bladder tube
|
42 | 19 | $318.00 | $59.11 |
|
76872
Ultrasound scan of pelvic region through rectum
|
40 | 40 | $312.00 | $31.93 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 559 | 43,573 | $6,278.53 | 179 |
| Abiraterone Acetate | Abiraterone Acetate | 346 | 10,740 | $814,712.08 | 40 |
| Finasteride | Finasteride | 344 | 29,626 | $4,078.98 | 108 |
| Prednisone | Prednisone | 302 | 10,620 | $1,204.45 | 39 |
| Xtandi | Enzalutamide | 213 | 6,390 | $2,790,284.43 | 24 |
| Orgovyx | Relugolix | 117 | 3,494 | $311,997.44 | 14 |
| Nubeqa | Darolutamide | 75 | 2,250 | $956,447.61 | — |
| Cephalexin | Cephalexin | 64 | 2,514 | $382.06 | 37 |
| Myrbetriq | Mirabegron | 62 | 3,772 | $55,678.67 | 20 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 268 | $187.96 | 32 |
| Erleada | Apalutamide | 34 | 1,020 | $425,854.14 | — |
| Silodosin | Silodosin | 31 | 2,790 | $3,413.51 | — |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | 1,293 | $499.61 | — |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 23 | 1,244 | $409.84 | — |
| Eligard | Leuprolide Acetate | 21 | 3,541 | $52,969.70 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | 915 | $220.11 | — |
| Prolia | Denosumab | 17 | 3,060 | $28,127.22 | 12 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 17 | 1,410 | $356.89 | — |
| Alendronate Sodium | Alendronate Sodium | 14 | 1,176 | $120.99 | — |
| Xgeva | Denosumab | 14 | 990 | $43,353.18 | — |
| Lynparza | Olaparib | 13 | 390 | $203,192.38 | — |
| Dutasteride | Dutasteride | 11 | 810 | $595.57 | — |
| Gemtesa | Vibegron | 11 | 720 | $11,547.10 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20160808000815
OH
9830328392
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Tri State Urologic Services Psc Inc
350 Thomas More Pkwy, Crestview Hills, KY 410175460
Phone: 8593632200
Tri State Urologic Services Psc Inc
4360 Ferguson Dr, Cincinnati, OH 452451683
Phone: 5138417750
Tri State Urologic Services Psc Inc
2000 Joseph E Sanker Blvd, Cincinnati, OH 452121979
Phone: 5138417400
Kentucky Rehabilitation Services, Inc.
580 Buttermilk Pike, Crescent Springs, KY 410171635
Phone: 8593416654
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated April 05, 2010.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Crestview Hills
- Christian Dewan
- Dr. James Williams, MD
- Dr. B Schwartz, MD
- Dr. Brian Shay, MD
- Dr. Christopher Cirulli, MD
- Dr. Michael Dusing, MD
Mailing Address
2000 Joseph E Sanker Blvd
Cincinnati, OH 452121979
Phone: 5138417400